Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer

Eur J Cancer. 2011 Sep:47 Suppl 3:S189-94. doi: 10.1016/S0959-8049(11)70164-2.
No abstract available

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use*
  • Carcinoma / pathology
  • Carcinoma / surgery
  • Carcinoma / therapy*
  • Humans
  • Male
  • Molecular Targeted Therapy / methods*
  • Neoplasm Metastasis
  • Orchiectomy
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery
  • Prostatic Neoplasms / therapy*
  • Rationalization
  • Receptors, Androgen* / genetics
  • Receptors, Androgen* / metabolism
  • Receptors, Androgen* / physiology
  • Signal Transduction / drug effects
  • Treatment Failure
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Receptors, Androgen